JANSSEN PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV |
TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICALS INDUSTRIES, LTD. |
2:2018cv00734 |
January 17, 2018 |
US District Court for the District of New Jersey |
Newark Office |
Mercer |
James B. Clark |
John Michael Vazquez |
Patent - Abbreviated New Drug Application |
35 U.S.C. ยง 271 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 281 USCA OPINION re 275 Notice of Appeal (Federal Circuit), filed by TEVA PHARMACEUTICALS USA, INC. (adc, ) |
Filing 271 OPINION. Signed by Judge Claire C. Cecchi on 10/8/2021. (ams, ) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.